Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F23V8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,994
Award facts
- Contract value 100% obligated
- $35,993.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,993.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on December 8, 2025, with completion scheduled for December 9, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
BIKTARVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the breadth of pharmaceutical products AmerisourceBergen supplies to federal medical procurement needs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen fulfills critical medical supply requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver diverse medications across multiple therapeutic domains, from specialty treatments to vaccines and medical supplies, all competitively awarded through open competition with consistent firm fixed pricing arrangements.
Quick answers
Who was awarded contract SPE2DR26F23V8?
SPE2DR26F23V8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F23V8 worth?
The government has obligated $35,994 on SPE2DR26F23V8.
Is contract SPE2DR26F23V8 an order under another contract?
Yes. SPE2DR26F23V8 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F23V8 competed?
The extent of competition for SPE2DR26F23V8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award